There are high hopes COVID-19 vaccines will help end the pandemic. However, there have been claims about these vaccines that have received mixed reactions from all quarters some advocating for the vaccines and others heavily criticizing the vaccines based on the manner in which the vaccines were hurriedly developed and approved raising safety and effectiveness concerns.

We sat down with Prof. Walter Jaoko, Director KAVI Institute of Clinical Research sheds more light on the safety to set the record straight on some of the myths circulating about COVID-19 vaccines.

It seems a lifetime ago since I joined KAVI as a scrawny pimply young doctor on 12th January 2004. After working 7 years at a busy A/E department, I knew clinical practice wasn’t for me. I had tried my hand in ENT surgery but that didn’t work out either. Somewhat lost and disillusioned, I needed out but didn’t know what I wanted. Joining KAVI was a stepping stone to the unknown. Little did I know then that in KAVI I would find the true purpose of my career in medicine in the field of clinical research.

Dr. Marianne Mureithi presented KAVI-ICR ground-breaking Mucosal Immunology work titled “Defining HIV-1 interactions at the Mucosa”  at the emerging techniques for investigating mucosal immunity and delivery of therapies symposium” held at the Anthony de Rothschild Lecture Theatre, St Mary’s Campus Imperial College London, UK on August 5th, 2019.